Five-Year watch: tracking a DMD Drug's Long-Term impact on boys and men
Disease control
Recruiting now
This study aims to gather more information on the long-term safety of the drug AGAMREE® (vamorolone) for people with Duchenne muscular dystrophy (DMD). It will follow about 250 male patients, aged 2 and older, for five years to monitor their health and see how the treatment affec…
Sponsor: Catalyst Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 08:27 UTC